- CEO
- Stephen Andrew Tomisich
- Full Time Employees
- 620
- Sector
- Commercial services
- Industry
- Miscellaneous commercial services
- Address
- 7 Argent Place Ringwood VIC Australia 3134
- IPO Date
- Jun 7, 2021
- Business
- Trajan Group Holdings Limited is a global developer and manufacturer of advanced analytical and life science products, devices, and integrated solutions, with operations spanning Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company operates through distinct segments: Components and Consumables, Capital Equipment, and Disruptive Technologies. Its analytical portfolio includes precision syringes, gas chromatography columns, septa, caps, liners, gas filters, ferrules, and various tubing, alongside sophisticated automation systems designed for the detailed analysis of biological, food, and environmental samples. In life sciences, Trajan offers specialized pathology products such as NBF containers, microscope slides, microtome blades, and tissue marking dyes. Furthermore, the company develops and supplies innovative microsampling devices, automation workflow tools, and sophisticated data analysis software, including platforms for mass spectrometry and protein structural analysis, all aimed at advancing personalized and data-driven healthcare. Founded in 2011, Trajan Group Holdings Limited maintains its corporate headquarters in Ringwood, Australia.